- Conditions
- Tinnitus
- Interventions
- Erchonia Hearing Lasers #1 & #2, Placebo Lasers
- Device
- Lead sponsor
- Erchonia Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Sacramento, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 409–432
of 8,191
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Alcohol Related Morbidity, Alcohol Dependence
- Interventions
- Brief Motivational Intervention, Assessment and list of resources, Referral to Community Resources
- Behavioral
- Lead sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- NIH
- Eligibility
- 14 Years to 21 Years
- Enrollment
- 1,400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts
- Conditions
- Stroke
- Interventions
- Functional Electric Stimulation (FES), Behavioral Assessments, Magnetic Resonance Imaging, EEG, RecoveriX, Delay, BCI-FES
- Device · Behavioral · Other
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 288 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2027
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Rheumatoid Arthritis
- Interventions
- suspension IR, CR 1, CR 2, CR 3
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Colon Adenoma, Colonoscopy
- Interventions
- Colonoscopy with water exchange or air insufflation methods
- Device
- Lead sponsor
- Dalin Tzu Chi General Hospital
- Other
- Eligibility
- 50 Years to 80 Years
- Enrollment
- 250 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Caries
- Interventions
- Oral Health Care Early Intervention Project
- Other
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- Up to 36 Months
- Enrollment
- 1,178 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 5
- States / cities
- Aurora, Colorado • Delta, Colorado • Fort Collins, Colorado + 2 more
- Conditions
- Chronic Pain, Pain, Musculoskeletal, Opioid Use, Physical Therapy
- Interventions
- Mindfulness based practice, Control/Standard Physical Therapy
- Behavioral
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 93 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 2
- States / cities
- Gainesville, Florida • Salt Lake City, Utah
- Conditions
- Healthy Study Participants
- Interventions
- glovadalen, Placebo
- Drug · Other
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Glendale, California
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Reprieve Decongestion Management System, Diuretic
- Device · Drug
- Lead sponsor
- Reprieve Cardiovascular, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 16
- States / cities
- Fairhope, Alabama • Irvine, California • Washington D.C., District of Columbia + 12 more
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Insulin glargine, Lispro Low Mix, Lispro Mid Mix, Lispro
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 30 Years to 79 Years
- Enrollment
- 2,091 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 138
- States / cities
- Mobile, Alabama • Litchfield Park, Arizona • Little Rock, Arkansas + 135 more
- Conditions
- Neural Tube Defects, Contraception, Oral Contraceptives (OC)
- Interventions
- Drospirenone/Ethinylestradiol/Methyltetrahydrofolate, Drospirenone/Ethinylestradiol (Yaz)
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 385 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2008
- U.S. locations
- 9
- States / cities
- Anaheim, California • San Diego, California • Baltimore, Maryland + 6 more
- Conditions
- Sprain, Strain, Acute Soft Tissue Injury
- Interventions
- Topical Ketoprofen 10% Cream, Topical Placebo Cream
- Drug
- Lead sponsor
- Imprimis Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 364 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Homework, Organization, and Planning Skills (HOPS) Intervention
- Behavioral
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Other
- Eligibility
- 11 Years to 15 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Preeclampsia, Gestational Hypertension
- Interventions
- spironolactone 25 mg orally once daily, Placebo tablet to match spironolactone
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 204 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts • Pittsburgh, Pennsylvania
- Conditions
- Overweight, Obesity
- Interventions
- Transcutaneous Nerve Stimulator (TENS), Diet & Exercise
- Device · Behavioral
- Lead sponsor
- Elira Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 77 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Diabetes, Type 2 Diabetes, Type 2 Diabetes Mellitus - Poor Control
- Interventions
- Continuous Glucose Monitor (CGM)
- Device
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Non-small Cell Lung Cancer Stage III
- Interventions
- Paclitaxel, Placebo for Veliparib, Carboplatin, Veliparib, Radiotherapy
- Drug · Radiation
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 12
- States / cities
- La Jolla, California • Newark, Delaware • Chicago, Illinois + 8 more
- Conditions
- Patellofemoral Pain Syndrome, Anterior Knee Pain Syndrome
- Interventions
- Blood Flow Restriction Cuff, Sham and standard of Care Therapy
- Device · Procedure
- Lead sponsor
- Gaylord Hospital, Inc
- Other
- Eligibility
- 15 Years and older
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 6
- States / cities
- Cheshire, Connecticut • Cromwell, Connecticut • Farmington, Connecticut + 2 more
- Conditions
- Chronic Hepatitis D Infection
- Interventions
- Libevitug 20 mg/kg, Libevitug 10 mg/kg, Delayed treatment with libevitug
- Drug · Other
- Lead sponsor
- Huahui Health
- Industry
- Eligibility
- 12 Years to 70 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Garden Grove, California
- Conditions
- Covid19
- Interventions
- Tempol, Placebo
- Drug · Other
- Lead sponsor
- Adamis Pharmaceuticals Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 248 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 17
- States / cities
- Anniston, Alabama • Los Angeles, California • Doral, Florida + 13 more
- Conditions
- Bronchopulmonary Dysplasia, Prematurity
- Interventions
- Protocolized weaning of respiratory support
- Other
- Lead sponsor
- Christiana Care Health Services
- Other
- Eligibility
- 22 Weeks to 30 Weeks
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Newark, Delaware
- Conditions
- Brain Injuries, Traumatic, Rehabilitation
- Interventions
- Bilingual Brain Injury Education and outpatient Navigation for Hispanic families
- Behavioral
- Lead sponsor
- Seattle Children's Hospital
- Other
- Eligibility
- 3 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 6
- States / cities
- Colorado Springs, Colorado • Portland, Oregon • Dallas, Texas + 2 more
- Conditions
- Suicide, Chronic Pain
- Interventions
- Problem-solving treatment, Supportive Psychotherapy
- Behavioral
- Lead sponsor
- Veterans BioMedical Research Institute
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- East Orange, New Jersey
- Conditions
- COVID-19, Corona Virus Infection, ARDS, Acute Respiratory Distress Syndrome
- Interventions
- Hydroxychloroquine, Placebo
- Drug · Other
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,483 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 2
- States / cities
- Minneapolis, Minnesota